These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1291 related articles for article (PubMed ID: 8725882)

  • 21. Relationship between secreted urokinase plasminogen activator activity and metastatic potential in murine B16 cells transfected with human urokinase sense and antisense genes.
    Yu HR; Schultz RM
    Cancer Res; 1990 Dec; 50(23):7623-33. PubMed ID: 1701350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma.
    Oniki S; Nagai H; Horikawa T; Furukawa J; Belladonna ML; Yoshimoto T; Hara I; Nishigori C
    Cancer Res; 2006 Jun; 66(12):6395-404. PubMed ID: 16778218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravesical liposome-mediated interleukin-2 gene therapy in orthotopic murine bladder cancer model.
    Horiguchi Y; Larchian WA; Kaplinsky R; Fair WR; Heston WD
    Gene Ther; 2000 May; 7(10):844-51. PubMed ID: 10845722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination surgery and nonviral interleukin 2 gene therapy for head and neck cancer.
    Li D; Jiang W; Bishop JS; Ralston R; O'Malley BW
    Clin Cancer Res; 1999 Jun; 5(6):1551-6. PubMed ID: 10389944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrotransfer of human IL-1Ra into skeletal muscles reduces the incidence of murine collagen-induced arthritis.
    Jeong JG; Kim JM; Ho SH; Hahn W; Yu SS; Kim S
    J Gene Med; 2004 Oct; 6(10):1125-33. PubMed ID: 15452879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effective gene transfer to solid tumors using different nonviral gene delivery techniques: electroporation, liposomes, and integrin-targeted vector.
    Cemazar M; Sersa G; Wilson J; Tozer GM; Hart SL; Grosel A; Dachs GU
    Cancer Gene Ther; 2002 Apr; 9(4):399-406. PubMed ID: 11960291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo targeting of gene expression to melanoma cells.
    Vile RG; Hart IR
    Cancer Res; 1993 Mar; 53(5):962-7. PubMed ID: 8439971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-18 gene transfer increases antitumor effects of suicide gene therapy through efficient induction of antitumor immunity.
    Ju DW; Yang Y; Tao Q; Song WG; He L; Chen G; Gu S; Ting CC; Cao X
    Gene Ther; 2000 Oct; 7(19):1672-9. PubMed ID: 11083476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct transfer of IL-12 gene into growing Renca tumors.
    Budryk M; Wilczyńska U; Szary J; Szala S
    Acta Biochim Pol; 2000; 47(2):385-91. PubMed ID: 11051203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-2 augmented activation of tumor associated macrophage plays the main role in MHC class I in vivo induction in tumor cells that are MHC negative in vitro.
    Ouyang GF; Saio M; Suwa T; Imai H; Nakagawa J; Nonaka K; Umemura N; Kijima M; Takami T
    Int J Oncol; 2006 May; 28(5):1201-8. PubMed ID: 16596236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retroviral-mediated transfer of genes encoding interleukin-2 and interleukin-12 into fibroblasts increases host antitumor responsiveness.
    Govaerts AS; Guillaume T; André M; Bayat B; Feyens AM; Hawley TS; Fong AZ; Hawley RG; Symann M
    Cancer Gene Ther; 1999; 6(5):447-55. PubMed ID: 10505855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunotherapy of established tumors in mice by intratumoral injection of interleukin-2 plasmid DNA: induction of CD8+ T-cell immunity.
    Saffran DC; Horton HM; Yankauckas MA; Anderson D; Barnhart KM; Abai AM; Hobart P; Manthorpe M; Norman JA; Parker SE
    Cancer Gene Ther; 1998; 5(5):321-30. PubMed ID: 9824052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complete regression of established subcutaneous B16 murine melanoma tumors after delivery of an HIV-1 Vpr-expressing plasmid by in vivo electroporation.
    McCray AN; Ugen KE; Muthumani K; Kim JJ; Weiner DB; Heller R
    Mol Ther; 2006 Nov; 14(5):647-55. PubMed ID: 16950655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The designer cytokine hyper-IL-6 mediates growth inhibition and GM-CSF-dependent rejection of B16 melanoma cells.
    Ozbek S; Peters M; Breuhahn K; Mann A; Blessing M; Fischer M; Schirmacher P; Mackiewicz A; Rose-John S
    Oncogene; 2001 Feb; 20(8):972-9. PubMed ID: 11314032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-2-secreting mouse fibroblasts transfected with genomic DNA from murine melanoma cells prolong the survival of mice with melanoma.
    Kim TS; Cohen EP
    Cancer Res; 1994 May; 54(10):2531-5. PubMed ID: 8168073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel cationic liposomes provide highly efficient delivery of DNA and RNA into dendritic cell progenitors and their immature offsets.
    Markov OO; Mironova NL; Maslov MA; Petukhov IA; Morozova NG; Vlassov VV; Zenkova MA
    J Control Release; 2012 Jun; 160(2):200-10. PubMed ID: 22155599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimization of cationic lipid/DNA complexes for systemic gene transfer to tumor lesions.
    Anwer K; Kao G; Proctor B; Rolland A; Sullivan S
    J Drug Target; 2000; 8(2):125-35. PubMed ID: 10852344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stabilized plasmid-lipid particles for regional gene therapy: formulation and transfection properties.
    Zhang YP; Sekirov L; Saravolac EG; Wheeler JJ; Tardi P; Clow K; Leng E; Sun R; Cullis PR; Scherrer P
    Gene Ther; 1999 Aug; 6(8):1438-47. PubMed ID: 10467368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of antitumor immunity against B16 melanoma tumor using genetically modified dendritic cells to produce cytokines.
    Akiyama Y; Watanabe M; Maruyama K; Ruscetti FW; Wiltrout RH; Yamaguchi K
    Gene Ther; 2000 Dec; 7(24):2113-21. PubMed ID: 11223993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eradication of melanoma pulmonary metastases by immunotherapy with tumor cells engineered to secrete interleukin-2 or gamma interferon.
    Abdel-Wahab Z; Dar M; Osanto S; Fong T; Vervaert CE; Hester D; Jolly D; Seigler HF
    Cancer Gene Ther; 1997; 4(1):33-41. PubMed ID: 9012449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 65.